| Ytd | -38.52% | |
| 1y | 9.61% |
| Open | 107.68 | Prev Close | 106.62 | Low | 106.01 | High | 109.19 | Mkt Cap | 23.19B |
| Vol | 2.35M | Avg Vol | 3.71M | EPS | -5.76 | P/E | N/A | Forward P/E | 771.55 |
| Beta | 0.77 | Short Ratio | 4.95 | Inst. Own | 106.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 112.09 | 200-d Avg | 151.92 | 1yr Est | 197.05 |
INSM News
Hannover, Germany, June 25, 2026 (GLOBE NEWSWIRE) -- EMBARC Announces Its Intention to Collaborate w
Evercore ISI Group analyst Josh Schimmer maintains Insmed (NASDAQ:INSM) with a Outperform and low
Nebius Group N.V. (NASDAQ: NBIS) stock surged on Tuesday after confirming its upcoming addition to t
CoreWeave, Astera Labs, Nebius, Rocket Lab & Teradyne join the Nasdaq-100. Jim Cramer calls this
CRWV stock climbs 5% as CoreWeave gears up to join the Nasdaq-100. Get the latest price action, incl
Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts OR
Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analys
JP Morgan analyst Jessica Fye maintains Insmed (NASDAQ:INSM) with a Overweight and lowers the pri
RBC Capital analyst Leonid Timashev maintains Insmed (NASDAQ:INSM) with a Outperform and lowers t